Sarcopenia is associated with lower step count in patients with peripheral artery disease following endovascular treatment

被引:1
|
作者
Takino, Koya [1 ,2 ,8 ]
Hara, Yasutaka [2 ]
Sakui, Daisuke [3 ]
Kawamura, Itta [4 ]
Kikuchi, Jun [5 ]
Komoda, Takuyuki [6 ]
Koeda, Tomoko [7 ]
机构
[1] Toyohashi Sozo Univ Sch Hlth Sci, Dept Phys Therapy, Toyohashi, Aichi, Japan
[2] Gifu Heart Ctr, Dept Cardiac Rehabil, Gifu, Gifu, Japan
[3] Co Ltd PREVENT, Nagoya, Aichi, Japan
[4] Gifu Heart Ctr, Dept Circulat, Gifu, Gifu, Japan
[5] Sugo Clin, Gifu, Japan
[6] Toyohashi Heart Ctr, Dept Plast Surg, Toyohashi, Aichi, Japan
[7] Nagoya Gakuin Univ, Fac Rehabil Sci, Nagoya, Aichi, Japan
[8] Toyohashi Sozo Univ, Dept Phys Therapy, 20-1 Matsushita, Toyohashi, Aichi, Japan
关键词
Endovascular treatment; physical activity; peripheral artery disease; sarcopenia; PHYSICAL-ACTIVITY QUESTIONNAIRE; QUALITY-OF-LIFE; RELIABILITY; EXERCISE; VALIDITY; STRENGTH; PEOPLE; PERFORMANCE; PEDOMETERS; INTENSITY;
D O I
10.1080/09593985.2024.2319780
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Introduction: Patients with peripheral artery disease (PAD) often complain of reduced physical activity (PA) despite improvements in intermittent claudication after successful endovascular treatment (EVT). Sarcopenia resulting from chronic ischemia can affect post-EVT PA levels. Objective: This study aims to assess the association between sarcopenia and post-EVT PA levels. Methods: One hundred five patients with PAD were consecutively enrolled in this study. PA was assessed using the post-EVT step count and the pre-EVT International Physical Activity Questionnaire. Sarcopenia was diagnosed based on the Asia Working Group for Sarcopenia and defined as low muscle mass and strength, and/or slow walking speed. The patients were categorized into three groups: 1) patients with sarcopenia (Sarcopenia Group); 2) patients with only low muscle mass or strength, and/or slow walking speed (Suspected-Sarcopenia Group); and 3) patients who did not fulfill all the sarcopenia criteria (No-Sarcopenia Group). Results: Proportions of patients in the Sarcopenia, Suspected-Sarcopenia, and No-Sarcopenia Groups were 31.4, 38.1, and 30.5%, respectively. After controlling for potential confounders, the Sarcopenia Group demonstrated significantly lower step counts than the Suspected-Sarcopenia Group (p = .016) and No-Sarcopenia Group (p = .009). Conclusions: Our findings indicate that patients with PAD and sarcopenia require rehabilitation strategies to enhance physical performance.
引用
收藏
页码:222 / 229
页数:8
相关论文
共 50 条
  • [31] Microvascular Disease Increases Amputation in Patients With Peripheral Artery Disease
    Behroozian, Adam
    Beckman, Joshua A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (03) : 534 - 540
  • [32] Treatment with cilostazol improves clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease
    Ishii, Hideki
    Aoyama, Toru
    Takahashi, Hiroshi
    Kumada, Yoshitaka
    Kamoi, Daisuke
    Sakakibara, Takashi
    Umemoto, Norio
    Suzuki, Susumu
    Tanaka, Akihito
    Ito, Yasuhiko
    Murohara, Toyoaki
    JOURNAL OF CARDIOLOGY, 2016, 67 (1-2) : 199 - 204
  • [33] Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial
    Moll, Frans
    Baumgartner, Iris
    Jaff, Michael
    Nwachuku, Chuke
    Tangelder, Marco
    Ansel, Gary
    Adams, George
    Zeller, Thomas
    Rundback, John
    Grosso, Michael
    Lin, Min
    Mercur, Michele F.
    Minar, Erich
    JOURNAL OF ENDOVASCULAR THERAPY, 2018, 25 (02) : 158 - 168
  • [34] Psychosocial outcome in cardiovascular rehabilitation of peripheral artery disease and coronary artery disease patients
    Stauber, Stefanie
    Guera, Viviane
    Barth, Juergen
    Schmid, Jean Paul
    Saner, Hugo
    Znoj, Hansjoerg
    Grolimund, Johannes
    von Kaenel, Roland
    VASCULAR MEDICINE, 2013, 18 (05) : 257 - 262
  • [35] Burning Bridges: Mechanisms and Implications of Endovascular Failure in the Treatment of Peripheral Artery Disease
    Roy, Trisha
    Forbes, Thomas
    Wright, Graham
    Dueck, Andrew
    JOURNAL OF ENDOVASCULAR THERAPY, 2015, 22 (06) : 874 - 880
  • [36] Surveillance After Surgical and Endovascular Treatment for Peripheral Artery Disease: a Dutch Survey
    Hoitz, Nathalie
    Kraima, Annelot
    Fioole, Bram
    Mees, Barend
    de Borst, Gert J.
    Unlu, Cagdas
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2024, 67 (06) : 980 - 986
  • [37] Exploring Possible Links: Thigh Muscle Mass, Apolipoproteins, and Glucose Metabolism in Peripheral Artery Disease-Insights from a Pilot Sub-Study following Endovascular Treatment
    Ikeda, Takeshi
    Komiyama, Hidenori
    Miyakuni, Tomoyo
    Takano, Masamichi
    Asai, Kuniya
    METABOLITES, 2024, 14 (04)
  • [38] Sarcopenia in patients following stroke: Prevalence and associated factors
    Ikeji, Rio
    Nozoe, Masafumi
    Yamamoto, Miho
    Seike, Haruka
    Kubo, Hiroki
    Shimada, Shinichi
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 233
  • [39] Optimal Strategy for Antiplatelet Therapy After Endovascular Revascularization for Lower Extremity Peripheral Artery Disease
    Cho, Sungsoo
    Lee, Yong-Joon
    Ko, Young-Guk
    Kang, Tae Soo
    Lim, Seong-Hoon
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (23) : 2359 - 2370
  • [40] Commentary: Contemporary Outcomes of Endovascular Interventions for Peripheral Artery Disease: The LIBERTY to Determine Optimal Treatment Strategies
    Armstrong, Ehrin J.
    Shishehbor, Mehdi H.
    JOURNAL OF ENDOVASCULAR THERAPY, 2019, 26 (02) : 155 - 157